An OPTIMISESSION titled "MARKET ACCESS: problems, investigations and solutions" was held on november 30, 2017

Publication date: 30 november 2017

On November 30, the Fitil movie theater hosted a business breakfast "Market Access: Problems, Investigations and Solutions".

Elena Danilova, Head of Market Access and Public Affairs, Aston Health, opened the event with a report "Market Access: To Say Is to Make It Happen". She provided a thorough overview of the requirements for inclusion of new drugs in EDL.

The next spokesman was Maria Avksentyeva, the Senior Scientist of HTA Laboratory at the Institute of Applied Economic Research (RANEPA), and the Adviser to the Head of the Center for Healthcare Quality Assessment and Control. Her report "Reimbursable Drugs Lists: New Rules for Drug Inclusion" highlighted the principal amendments in this area and triggered extensive discussion among the participants.

Larisa Popovich, Director of Health Economics Institute spoke about the new strategies for marketing and promotion of innovative medications.

Maria Sdvizhkova, Head of Strategic Consulting, Aston Health made a presentation on proprietary MA tools designed by Aston Health to help automate data analysis and processing (PharmCompass, Regional Stakeholder Mapping Tool and Market Access-360).

The invited guests showed a lot of interest in discussing all the presented issues at length. We hope the provided answers would be useful to many. We would like to thank everyone who attended our business breakfast!

See you at the next Optimisession!